| Mrs Rhonda Newberry Hildreth, LSCSW | |
|
425 N Baltimore Ave, Suite 1, Derby, KS 67037-1641 | |
| (316) 788-2200 | |
| (316) 788-1514 |
| Full Name | Mrs Rhonda Newberry Hildreth |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 425 N Baltimore Ave, Derby, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477566651 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1944 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rhonda Newberry Hildreth, LSCSW 425 N Baltimore Ave, Suite 1, Derby, KS 67037-1641 Ph: (316) 788-2200 | Mrs Rhonda Newberry Hildreth, LSCSW 425 N Baltimore Ave, Suite 1, Derby, KS 67037-1641 Ph: (316) 788-2200 |
News Archive
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.
While obesity is a well-known cause of cardiovascular disease, research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, has now revealed that the body's obesity hormones - adiponectin - are also linked to osteoporosis and an increased risk of fractures.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the Company has raised € 2.5 million in new equity by means of a private placement to three of its existing shareholders: Forbion Capital Partners, Gilde Healthcare Partners and Advent Venture Partners.
› Verified 3 days ago
Indy Marie Fairbanks, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1221 N Rock Rd Ste 100, Derby, KS 67037 Phone: 316-789-8511 | |
Mrs. Catherine I Baker, LMSW LSCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 425 N Baltimore, Ste 1, Derby, KS 67037 Phone: 316-788-2200 Fax: 316-788-1514 | |
Angela Mcghee, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1525 N Buckner St, Derby, KS 67037 Phone: 316-788-6464 Fax: 206-299-1262 | |
Dr. Alicia M Landsverk, PHD, LSCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1721 E Osage Rd, Ste 300, Derby, KS 67037 Phone: 316-788-1907 Fax: 316-788-1941 |